C. Diff News and Research

RSS

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

New research from the University of Virginia School of Medicine sheds light on why a fecal transplant can benefit patients with dangerous recurrent C. difficile infections – and suggests a way to improve patient outcomes.

14 Dec 2021

Study supports the implementation of Beckman Coulter’s MDW in emergency labs as initial test to detect sepsis

Beckman Coulter announced the results of a prospective study carried out across two European hospitals, which found that Monocyte Distribution Width, in combination with White Blood Cell Count with Differential, has the diagnostic accuracy to detect the risk of sepsis and severe infection upon patient presentation in A&E, particularly when assessed in patients with a lower likelihood of sepsis.

22 Sep 2021

Bacteriophages named after Norfolk village of Colney could help combat C. difficile infections

Viruses have a menacing reputation for causing disease but some that target bacteria could actually benefit human health.

5 Aug 2021

Researchers shed light on the microbial connection between very-low-calorie diet and weight loss

Researchers at UCSF have found that extreme caloric restriction diets alter the microbiome in ways that could help with weight loss but might also result in an increased population of Clostridiodes difficile, a pathogenic bacterium that can lead to severe diarrhea and colitis.

24 Jun 2021

New microbial genes responsible for bile acid conversion is a major step forward for gut health

As the owner of a human body, you're carrying trillions of microbes with you everywhere you go. These microscopic organisms aren't just hitching a ride; many of them perform essential chemical reactions that regulate everything from our digestion to our immune system to our moods.

27 May 2021

Study uncovers molecular reason why fecal transplants effectively treat C. difficile infections

Experts have uncovered a new molecular reason why faecal transplants are highly effective in treating infections such as C. difficile (a nasty bacteria that can infect the bowel), which could lead to more targeted treatments for this and other similar diseases.

9 Apr 2021

University of Strathclyde signs licensing deal for its patented HINS-light technology

The new Environment Care Lighting technology range created by Linea Light Group using High Intensity Narrow Spectrum (HINS) light developed and patented by the University of Strathclyde in Glasgow, will enable the Woofer and Rollip appliances from the i-LèD Professional collection to decontaminate surfaces and prevent infection, destroying up to 70-80% of bacteria with continuous use.

22 Mar 2021

Study: Vast majority of U.S. infants may be suffering from gut microbiome deficiency

A new peer-reviewed study reveals that the vast majority of U.S. infants may be suffering from a substantial deficiency in an important bacterium key to breast milk utilization and immune system development, as well as protection against gut pathogens linked to common newborn conditions such as colic and diaper rash.

21 Jan 2021

Inflammation may contribute to the persistence of C. diff infection, shows study

A new study from North Carolina State University shows that the inflammation caused by Clostridioides difficile (C. diff) infection gives the pathogen a two-fold advantage: by both creating an inhospitable environment for competing bacteria and providing nutrients that enable C. diff to thrive.

19 Jan 2021

C. Diff News and Research

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

Study supports the implementation of Beckman Coulter’s MDW in emergency labs as initial test to detect sepsis

Bacteriophages named after Norfolk village of Colney could help combat C. difficile infections

Researchers shed light on the microbial connection between very-low-calorie diet and weight loss

New microbial genes responsible for bile acid conversion is a major step forward for gut health

Study uncovers molecular reason why fecal transplants effectively treat C. difficile infections

University of Strathclyde signs licensing deal for its patented HINS-light technology

Study: Vast majority of U.S. infants may be suffering from gut microbiome deficiency

Inflammation may contribute to the persistence of C. diff infection, shows study

Children’s hospitals are partly to blame as superbugs increasingly attack kids

New guidelines improved the ability to predict C. diff infection mortality

Researchers advance novel compounds to help treat C. difficile infection

UVA now supports engineering-to-medicine faculty fellowships

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

Fecal transplants could be used as treatment for non-alcoholic fatty liver disease

Revolutionary air disinfection system protects dentists against COVID-19

UDCA treatment affects C. diff life cycle, reduces inflammatory response in mice

Consistent guidelines for treating urinary tract infections

Fecal Microbiota Transplants highly successful in treating patients with C.diff infection

Diets high in fat and protein exacerbate C. diff infections in mice

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News